Saxenda Savings Card (2026)

By GLP1Copay.com editorial team · Reviewed by Sarah Mitchell, PharmD · Last reviewed: May 13, 2026 Drug pricing verified May 2026 against manufacturer pages.

Important: Drug pricing and savings programs change frequently. Verify current eligibility directly with the manufacturer before applying. This content is not medical or financial advice.
Quick Verdict

Saxenda has a lower savings cap than newer GLP-1 drugs, but the program is still active for commercially insured patients. If you are stable on Saxenda and have commercial insurance, the savings card is worth activating.

What saves you money

  • +Program still active as of May 2026
  • +Reduces out-of-pocket costs for commercial plans
  • +Works for adults with BMI criteria

Watch out for

  • !Lower cap (~$200/mo) vs Wegovy/Zepbound
  • !Daily injection vs weekly for newer options
  • !No Medicare or Medicaid

Verify at saxenda.com. If starting GLP-1 treatment fresh, compare with Wegovy and Zepbound programs.

Apply for the Saxenda savings card

Go to Official Saxenda Savings Page
Important: Drug pricing and savings programs change frequently. Verify current eligibility directly with the manufacturer before applying. This content is not medical or financial advice.

Primary Sources

Related guides on this site

Frequently Asked Questions

How much does Saxenda cost with the savings card?

Eligible commercially insured patients can save up to approximately $200/month on Saxenda. Your actual out-of-pocket cost depends on your plan's formulary placement for Saxenda. Without insurance the list price is approximately $1,349/month.

Is Saxenda still available or has it been discontinued?

Saxenda (liraglutide) is still available as of May 2026, but Novo Nordisk has shifted marketing focus to Wegovy (semaglutide), which produces more weight loss in clinical trials. Many doctors still prescribe Saxenda, particularly for patients who have been stable on it for years.

What is the difference between Saxenda and Wegovy?

Saxenda contains liraglutide and is injected daily. Wegovy contains semaglutide and is injected once weekly. The STEP and SCALE clinical trials show Wegovy produces about 15% average body weight loss versus 8% for Saxenda. Wegovy is generally preferred for new starts. Saxenda may be tolerated better by some patients sensitive to GI side effects.

Can Medicare patients get the Saxenda savings card?

No. Like all manufacturer copay cards, Saxenda's savings offer cannot be used with Medicare, Medicaid, or other government-funded plans. Medicare patients should ask their provider about the NovoCare Patient Assistance Program or LIS Extra Help for Part D.

Does the Saxenda savings card expire?

Novo Nordisk can modify or end the program at any time. Cards typically remain valid for 12 months from activation. Always verify current terms at saxenda.com before filling each prescription.

Who qualifies for the Saxenda savings card?

Adults 18 and older with commercial insurance (employer, marketplace, or individual private plan), a Saxenda prescription for weight management (BMI 30+ or 27+ with comorbidity), and US residency. Government plan enrollees are not eligible.

Can I switch from Saxenda to Wegovy and keep using a savings card?

Yes. The Wegovy savings card is a separate program from the Saxenda card. If your doctor switches your prescription, deactivate the Saxenda card and apply for the Wegovy card at wegovy.com.

Is Saxenda covered by insurance?

Coverage varies. Most commercial plans require prior authorization showing BMI eligibility and prior weight management attempts. Medicare Part D does not cover Saxenda or other anti-obesity GLP-1 drugs under current federal law (this may change if pending legislation passes).